(ATXI) Avenue Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Avenue Therapeutics | (ATXI) share price targets
Complete technical analysis of Avenue Therapeutics (ATXI) by charts plus indicators, forecast predictions and share price targets for Avenue Therapeutics (ATXI)
Avenue Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-01 View latest technical analysis
10 day averaged volume of Avenue Therapeutics is 114070
| Date | Daily Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 2.24 | 2.42 | 2.48 | 2.18 | 0.891 times |
| 31 Thu Oct 2024 | 2.40 | 2.46 | 2.49 | 2.38 | 0.444 times |
| 30 Wed Oct 2024 | 2.40 | 2.55 | 2.55 | 2.36 | 0.367 times |
| 29 Tue Oct 2024 | 2.45 | 2.47 | 2.57 | 2.41 | 0.553 times |
| 28 Mon Oct 2024 | 2.52 | 2.35 | 2.63 | 2.20 | 1.96 times |
| 25 Fri Oct 2024 | 2.20 | 2.14 | 2.29 | 2.02 | 1.227 times |
| 24 Thu Oct 2024 | 2.02 | 2.09 | 2.14 | 2.00 | 0.277 times |
| 23 Wed Oct 2024 | 2.10 | 2.05 | 2.15 | 2.01 | 0.163 times |
| 22 Tue Oct 2024 | 2.11 | 2.00 | 2.11 | 1.94 | 0.347 times |
| 21 Mon Oct 2024 | 2.00 | 2.60 | 2.70 | 1.94 | 4.424 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 2.3 as stoploss in an intra day sell trade for a target of 2.14. However, stock will show a bullish move above 2.3.
Share price targets for Avenue Therapeutics (ATXI)
| Target Type | Value |
| Downside Target | 1.70 |
| Downside Target | 1.90 |
| Downside Target | 1.94 |
| Downside Target | 2.07 |
| Downside Target | 2.18 |
| Upside Target | 2.41 |
| Upside Target | 2.48 |
| Upside Target | 2.55 |
| Upside Target | 2.63 |
| Upside Target | 2.70 |
| Upside Target | 3.07 |
| Upside Target | 3.54 |
| Upside Target | 3.93 |
Intraday share price targets for Avenue Therapeutics (ATXI)
| Target Type | Value |
| Downside Intraday Target | 2.07 |
| Downside Intraday Target | 1.9 |
| Upside Intraday Target | 2.52 |
| Upside Intraday Target | 2.8 |
| Upside Intraday Target | 2.35 |
Weekly technical analysis of Avenue Therapeutics (ATXI)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 2.24 | 2.35 | 2.63 | 2.18 | 0.655 times |
| 25 Fri Oct 2024 | 2.20 | 2.60 | 2.70 | 1.94 | 2.075 times |
| 18 Fri Oct 2024 | 2.11 | 2.09 | 2.41 | 1.70 | 2.782 times |
| 11 Fri Oct 2024 | 2.06 | 2.10 | 2.29 | 1.90 | 1.728 times |
| 04 Fri Oct 2024 | 2.08 | 2.50 | 2.55 | 2.07 | 0.404 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Avenue Therapeutics (ATXI)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 01 Fri Nov 2024 | 2.24 | 2.42 | 2.48 | 2.18 | 0.062 times |
| 31 Thu Oct 2024 | 2.40 | 2.42 | 2.70 | 1.70 | 2.885 times |
| 30 Mon Sep 2024 | 2.49 | 2.75 | 3.54 | 2.21 | 0.981 times |
| 30 Fri Aug 2024 | 2.54 | 2.91 | 3.07 | 2.25 | 0.353 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Avenue Therapeutics (ATXI)
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Avenue Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Avenue Therapeutics in short term but the buy signal is initial and weak.
Avenue Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Avenue Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Avenue Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.2 and Avenue Therapeutics (ATXI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Avenue Therapeutics (ATXI) stock. Volume based technical analysis of Avenue Therapeutics (ATXI) stock is negative.
Avenue Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Avenue Therapeutics ( (ATXI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Avenue Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Avenue Therapeutics in short term but the buy signal is initial and weak.
Avenue Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Avenue Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Avenue Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.2 and Avenue Therapeutics (ATXI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Avenue Therapeutics (ATXI) stock. Volume based technical analysis of Avenue Therapeutics (ATXI) stock is negative.
Avenue Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.